Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 Por Atkinson, Jennifer M., Rank, Kenneth B., Zeng, Yi, Capen, Andrew, Yadav, Vipin, Manro, Jason R., Engler, Thomas A., Chedid, Marcio

Obter o texto integral